Key result
Moxonidine is an effective antihypertensive, but its use in heart failure is contraindicated due to excessive deaths observed in the MOXCON trial.
Why the study?
What is the mechanism of action, efficacy, and safety profile of moxonidine in hypertension and heart failure?
Population
Patients with hypertension and patients with heart failure; animal models of hypertension, diabetes, kidney…
Design
Review
Authors
Loading...
Caution against heart failure use persists; confirms MOXCON mortality signal while leaving comparative efficacy unresolved.
What is the mechanism of action, efficacy, and safety profile of moxonidine in hypertension and heart failure?
Moxonidine is an effective antihypertensive agent but is strictly contraindicated in patients with heart failure due to increased mortality risk.
Sheila A Doggrell (2001) conducted a review in Hypertension and Heart Failure. Moxonidine was evaluated. Moxonidine is an effective antihypertensive, but its use in heart failure is contraindicated due to excessive deaths observed in the MOXCON trial.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: